Jeffrey Tepper

Title: The Innovative Contributions of Jeffrey Tepper

Introduction

Jeffrey Tepper is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary disorders and cancer. With a total of 2 patents, Tepper's work has the potential to impact the lives of many individuals suffering from these conditions.

Latest Patents

Tepper's latest patents include innovative methods for treating asthma in both human and non-human primates using IL-4 mutant compositions. This invention focuses on the inhalation administration of hIL-4 mutant proteins to effectively treat asthma. Another significant patent involves the use of the Parapox B2L protein to treat cancer and modify immune responses. This purified envelope protein, termed 'B2L', can serve as a monotherapeutic agent and is also useful in screening methods to identify potential therapeutic agents for modulating a subject's immune response.

Career Highlights

Throughout his career, Jeffrey Tepper has worked with prominent companies such as Bayer Pharmaceuticals Corporation and Aerovance, Inc. His experience in these organizations has contributed to his expertise in developing innovative medical treatments.

Collaborations

Tepper has collaborated with various professionals in his field, including Delanie Cassell and Isa Samuels. These partnerships have likely enhanced his research and development efforts.

Conclusion

Jeffrey Tepper's contributions to medical innovation, particularly in asthma and cancer treatment, highlight his role as a significant inventor. His patents reflect a commitment to advancing healthcare solutions that can improve patient outcomes.